Indore: In a first in the city, two receive anti-body drug cocktail

Staff ReporterUpdated: Friday, May 28, 2021, 12:05 AM IST
article-image
Representative Photo | AFP

Indore: In a first in the city, two patients admitted to MRTB Hospital were administered with the antibody drug cocktail for the treatment COVID-19. The patients received the doses on Wednesday and doctors claimed that they didn't get expected results so far.

“The monoclonal antibody drug was given to the patients aged 40 and 45 years on Wednesday. These patients have been admitted to the hospital for the last 5-7 days,”respiratory medicine expert Dr Deepak Bansal told the media.

He added that the oxygen level of these patients was around 90 and they required 70 to 80 per cent of oxygen.

“Patients were administered with the dose of Casirivimab and Imdevimab through saline. As per the studies, the drug is beneficial for the patients in the early stage of COVID infection and we are still monitoring the results of the same drugs,” Dr Bansal said.

Doctors preferred to give steroids to patients in early stage as the antibody cocktail is expensive.

“We will administer the drug to patients with diabetes as steroids shoot up their blood sugar levels. We will monitor the results of the medicines in diabetic patients.

The antibody cocktail shot into the limelight after it was used to treat former United States President Donald Trump last year. The therapy is said to reduce the chance of hospitalisation by 70 per cent in patients with mild to moderate Covid-19 symptoms.

What is an antibody cocktail?

The therapy is a cocktail of two monoclonal antibodies. Monoclonal antibodies are artificially created in a laboratory and tailor-made to fight a particular disease. Casirivimab and imdevimab, which are part of the antibody cocktail produced by Switzerland-based Roche, are specifically directed against the spike protein of SARS-CoV-2. They block the virus's attachment and subsequent entry into human cells.

Woman who was given DRDO’s 2-DG to be discharged soon

The 70-year-old woman Santosh Goyal, who was given a 2-DG drug developed by DRDO, would be discharged from the hospital in a couple of days.
The family members received 10 sachets of the drug from DRDO which were given to the patient. Goyal’s son Shirish claimed that his mother got immediate relief by the drug and her oxygen dependency was reduced.

(To receive our E-paper on whatsapp daily, please click here. To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

'We got respect only after 10 years': Kapil Dev on his 1983 World Cup-winning team not getting...

'We got respect only after 10 years': Kapil Dev on his 1983 World Cup-winning team not getting...

Harmanpreet Kaur overtakes Mithali Raj to become India's leading run-scorer in women's T20Is

Harmanpreet Kaur overtakes Mithali Raj to become India's leading run-scorer in women's T20Is

Warm-up game: Virat Kohli hits 67, Shreyas Iyer slams 62 as India finish Day Three on 364-7 against...

Warm-up game: Virat Kohli hits 67, Shreyas Iyer slams 62 as India finish Day Three on 364-7 against...

Daily Horoscope for Sunday, June 26, 2022, for all zodiac signs by astrologer Vinayak Vishwas...

Daily Horoscope for Sunday, June 26, 2022, for all zodiac signs by astrologer Vinayak Vishwas...

Mumbai: Victim a girl of modern era, was in love relation with accused, says POCSO court

Mumbai: Victim a girl of modern era, was in love relation with accused, says POCSO court